Cargando…

The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda

BACKGROUND: The Oral Polio Vaccine (OPV or Sabin) is genetically unstable and may mutate to form vaccine-derived polioviruses (VDPVs). METHODS: In 2014, two VDPVs type 2 were identified during routine surveillance of acute flaccid paralysis (AFP) cases. Consequently, a retrospective VDPV survey was...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanteza, Mary Bridget, Bakamutumaho, Barnabas, Kisakye, Annet, Namuwulya, Prossy, Bukenya, Henry, Katushabe, Edson, Bwogi, Josephine, Byabamazima, Charles Rutebarika, Williams, Raffaella, Gumede, Nicksy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922010/
https://www.ncbi.nlm.nih.gov/pubmed/29699577
http://dx.doi.org/10.1186/s12985-018-0990-y
_version_ 1783318127137783808
author Nanteza, Mary Bridget
Bakamutumaho, Barnabas
Kisakye, Annet
Namuwulya, Prossy
Bukenya, Henry
Katushabe, Edson
Bwogi, Josephine
Byabamazima, Charles Rutebarika
Williams, Raffaella
Gumede, Nicksy
author_facet Nanteza, Mary Bridget
Bakamutumaho, Barnabas
Kisakye, Annet
Namuwulya, Prossy
Bukenya, Henry
Katushabe, Edson
Bwogi, Josephine
Byabamazima, Charles Rutebarika
Williams, Raffaella
Gumede, Nicksy
author_sort Nanteza, Mary Bridget
collection PubMed
description BACKGROUND: The Oral Polio Vaccine (OPV or Sabin) is genetically unstable and may mutate to form vaccine-derived polioviruses (VDPVs). METHODS: In 2014, two VDPVs type 2 were identified during routine surveillance of acute flaccid paralysis (AFP) cases. Consequently, a retrospective VDPV survey was conducted to ensure that there was no circulating VDPV in the country. All Sabin poliovirus isolates identified in Uganda 6 months before and 6 months after were re-screened; Sabin 1 and 3 polioviruses were re-screened for Sabin 2 and Sabin 2 polioviruses were re-screened for VDPVs type 2. The Poliovirus rRT-PCR ITD/VDPV 4.0 assay and sequencing were used respectively. RESULTS: The first two VDPVs type2 were identified in Eastern Uganda and the third was identified during the survey from South-western Uganda. These regions had low OPV coverage and poor AFP surveillance indicators. CONCLUSION: The retrospective VDPV survey was a useful strategy to screen for VDPVs more exhaustively. Supplementary surveillance methods need to be encouraged. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12985-018-0990-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5922010
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59220102018-05-07 The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda Nanteza, Mary Bridget Bakamutumaho, Barnabas Kisakye, Annet Namuwulya, Prossy Bukenya, Henry Katushabe, Edson Bwogi, Josephine Byabamazima, Charles Rutebarika Williams, Raffaella Gumede, Nicksy Virol J Research BACKGROUND: The Oral Polio Vaccine (OPV or Sabin) is genetically unstable and may mutate to form vaccine-derived polioviruses (VDPVs). METHODS: In 2014, two VDPVs type 2 were identified during routine surveillance of acute flaccid paralysis (AFP) cases. Consequently, a retrospective VDPV survey was conducted to ensure that there was no circulating VDPV in the country. All Sabin poliovirus isolates identified in Uganda 6 months before and 6 months after were re-screened; Sabin 1 and 3 polioviruses were re-screened for Sabin 2 and Sabin 2 polioviruses were re-screened for VDPVs type 2. The Poliovirus rRT-PCR ITD/VDPV 4.0 assay and sequencing were used respectively. RESULTS: The first two VDPVs type2 were identified in Eastern Uganda and the third was identified during the survey from South-western Uganda. These regions had low OPV coverage and poor AFP surveillance indicators. CONCLUSION: The retrospective VDPV survey was a useful strategy to screen for VDPVs more exhaustively. Supplementary surveillance methods need to be encouraged. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12985-018-0990-y) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-27 /pmc/articles/PMC5922010/ /pubmed/29699577 http://dx.doi.org/10.1186/s12985-018-0990-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Nanteza, Mary Bridget
Bakamutumaho, Barnabas
Kisakye, Annet
Namuwulya, Prossy
Bukenya, Henry
Katushabe, Edson
Bwogi, Josephine
Byabamazima, Charles Rutebarika
Williams, Raffaella
Gumede, Nicksy
The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda
title The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda
title_full The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda
title_fullStr The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda
title_full_unstemmed The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda
title_short The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda
title_sort detection of 3 ambiguous type 2 vaccine-derived polioviruses (vdpv2s) in uganda
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922010/
https://www.ncbi.nlm.nih.gov/pubmed/29699577
http://dx.doi.org/10.1186/s12985-018-0990-y
work_keys_str_mv AT nantezamarybridget thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT bakamutumahobarnabas thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT kisakyeannet thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT namuwulyaprossy thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT bukenyahenry thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT katushabeedson thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT bwogijosephine thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT byabamazimacharlesrutebarika thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT williamsraffaella thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT gumedenicksy thedetectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT nantezamarybridget detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT bakamutumahobarnabas detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT kisakyeannet detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT namuwulyaprossy detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT bukenyahenry detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT katushabeedson detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT bwogijosephine detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT byabamazimacharlesrutebarika detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT williamsraffaella detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda
AT gumedenicksy detectionof3ambiguoustype2vaccinederivedpoliovirusesvdpv2sinuganda